During a fiery U.S. Senate hearing, FBI Director Kash Patel clashed with Senator Patty Murray after she accused him of politicising the bureau. Patel shot back sharply, declaring, “I’m not going to ...

The House Foreign Affairs Committee held a high-stakes hearing focused on countering Iran’s growing threats. The session ...

The 17-year-old student athlete, Austin Metcalf, who was fatally stabbed at a track meet in April was invoked in the Oval Office as President Trump signed an executive order that seeks to strengthen ...

There’s a lot that goes on inside our brains. But there are times that our minds go… well… what’s the word? Blank? Reviewing available research on mind ...

The Scout's panel of Fantasy Premier League experts reveal who they are planning to captain in Blank Gameweek 34 (BGW34) ahead of the deadline at 11:00 BST on Saturday 26 April. Fantasy Premier League ...

US President Donald Trump and Vice President JD Vance meet with Ukrainian President Volodymyr Zelensky in the Oval Office at the White House in ... We are very close to a deal but the man with “no ...

Pahalgam: “Whoever recited Kalma were spared, the rest were shot at point blank range,” recalled Aijaz, a 38-year-old photographer who recited the Islamic verses when confronted at gunpoint by the ...

Personal and small business cards issued by U.S. Bank, Discover and Bank of America cards are currently not available on CNBC Select and links have been redirected to our credit card marketplace ...

SBI Cards and Payment Services Ltd. will announce the results for the fourth quarter and the full financial year 2024-25 this week. The credit cards and payment services arm of the State Bank of India ...

If you have a balance on your credit card, you might have the option to pay it off in full or carry it from month to month. Most of the time, paying off your credit card in full is the best approach.

The powerhouse actor on learning from his father Roy, his love of Sondheim, navigating fame, and who should play the next ...

Veraxa Biotech, a cancer therapy developer backed by Swiss incubator Xlife Sciences, will go public through a combination with a blank-check entity in a deal that will value the company at as much as ...